+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Asia Pacific Diabetes Care Devices Market to 2027 - Regional Analysis and Forecasts by Product; End User; and Country

  • ID: 4801440
  • Report
  • Region: Asia, Asia Pacific
  • 152 pages
  • The Insight Partners
UP TO OFF
until Jan 15th 2020
1 of 3

FEATURED COMPANIES

  • B. Braun Melsungen AG
  • BD
  • Dexcom, Inc.
  • Eli Lilly and Company
  • F. Hoffman-LA Roche Ltd.
  • Insulet Corporation
  • MORE
The Asia Pacific diabetes care devices market is expected to reach US$ 8,880.7 Mn in 2027 from US$ 5,011.5 Mn in 2018. The market is estimated to grow with a CAGR of 6.7% from 2019-2027.

The growth of the diabetes care devices market is primarily attributed to the rapid technological advancements in diabetes care devices and increasing rate of obesity. However, high cost of diabetes care devices and increasing prevalence of type 2 diabetes are likely to pose a negative impact on the market growth. On the other hand, growing medical tourism in developing countries is likely to have a positive impact on the growth of the Asia Pacific diabetes care devices market in the coming years.

The advancement in the field of the healthcare industry is driving to the players for more research and developments for the diabetes care devices for the administration purpose required during various medical conditions. The pen needles used in various injection pens have evolved gradually in terms of material, performance, dimensions and safety factors such as sterility and safety packaging. Various manufacturers are coming up with innovative products to sustain in the highly fragmented diabetes care devices market, in the region. Moreover, the easy regulatory approvals in the Asian countries has led to mid-sized companies enter the market and compete with the local and established players. For instance, in May 2018, Hindustan Syringes and Medical Devices (HMD), one of the leading manufacturers of disposable syringes introduced “Dispovan” insulin pen needle which is the first made-in-India disposable pen needle that is technologically efficient and affordable than that of the currently available products in the market. Development of pen needles with precise lubrication to reduce the pain sensation has been another focus of manufacturers during the research. Thus, owing to the above mentioned factors the market for diabetes care devices anticipated to grow rapidly in the forecast period, in the region.

In 2018, the glucose monitoring devices segment held a largest market share of 54.0% of the diabetes care devices market, by product. The glucose monitoring devices is expected to dominate its market share in 2027 owing to the rise in the prevalence of the type 2 diabetes in the region. The testing strips segment among the glucose monitoring devices is anticipated to witness the fastest growth rate of 7.6% during the forecast period, 2019 to 2027 owing to the enormous usages in the glucose monitoring devices.

Homecare held a largest market share of 59.8% of the diabetes care devices market, by end user. This segment is also expected to dominate the market in 2027 owing to the rise in the demand for the glucose monitoring devices and insulin delivery devices. Increasing prevalence of diabetes, the ease of use, availability, and accessibility of insulin delivery devices has also increased the adoption of self-administration among patients is anticipated to grow at a steady rate during the forecast period. Also the homecare segment is also expected to grow at the fastest growth rate of 6.9% during the forecast period, 2019 to 2027.

Some of the major primary and secondary sources for diabetes care devices included in the report are, China Initiative for Diabetes Excellence (CIDE), Centers for Diabetes and Endocrinology (CDE), Public Health England (PHE), Centers for Disease Control and Prevention (CDC), Food and Drug Administration (FDA), International Diabetes Federation (IDF) and others.
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • B. Braun Melsungen AG
  • BD
  • Dexcom, Inc.
  • Eli Lilly and Company
  • F. Hoffman-LA Roche Ltd.
  • Insulet Corporation
  • MORE
1. Introduction
1.1 Scope Of The Study
1.2 Report Guidance

2. Asia Pacific Diabetes Care Devices Market - Key Takeaways

3. Asia Pacific Diabetes Care Devices Market - Market Landscape
3.1 Overview
3.2 Market Segmentation
3.2.1 Asia Pacific Diabetes Care Devices Market - By Product
3.2.2 Asia Pacific Diabetes Care Devices Market - By End User
3.2.3 Asia Pacific Diabetes Care Devices Market - By Country
3.3 PEST Analysis

4. Asia Pacific Diabetes Care Devices Market - Key Market Dynamics
4.1 Key Market Drivers
4.1.1 Rapid Technological Advancements in Diabetes Care Devices
4.1.2 Increasing Rate of Obesity
4.2 Key Market Restraints
4.2.1 High Cost of Diabetes Care Devices
4.2.2 Increasing prevalence of Type 2 Diabetes
4.3 Key Market Opportunities
4.3.1 Growing Medical Tourism In Developing Countries
4.4 Future Trends
4.4.1 Increasing Prevalence of Obesity Across The Region
4.5 Impact Analysis

5. Diabetes Care Devices Market - Asia Pacific Analysis
5.1 Asia Pacific Diabetes Care Devices Market Revenue Forecasts And Analysis
5.2 Market Positioning
5.3 Performance of Key Players
5.3.1 Medtronic
5.3.2 F. Hoffmann-La Roche Ltd.

6. Asia Pacific Diabetes Care Devices Market Analysis - By Product
6.1 Overview
6.2 Asia Pacific Diabetes Care Devices Market By Product, 2018 & 2027 (%)
6.3 Asia Pacific Diabetes Care Devices Market Revenue And Forecasts To 2027, By Product (Us$ Mn)
6.3.1 Asia Pacific Glucose Monitoring Devices Market Revenue And Forecasts to 2027, By Type (US$ Mn)
6.3.2 Asia Pacific Insulin Delivery Devices Market Revenue And Forecasts to 2027, By Type (US$ Mn)
6.4 Glucose Monitoring Devices Market
6.4.1 Overview
6.4.2 Asia Pacific Glucose Monitoring Devices Market Revenue and Forecast to 2027 (US$ Mn)
6.4.3 Glucometers Market
6.4.3.1 Overview
6.4.3.2 Asia Pacific Glucometers Market Revenue and Forecast to 2027 (US$ Mn)
6.4.4 Lancets Market
6.4.4.1 Overview
6.4.4.2 Asia Pacific Lancets Market Revenue and Forecast to 2027 (US$ Mn)
6.4.5 Testing Strips Market
6.4.5.1 Overview
6.4.5.2 Asia Pacific Testing Strips Market Revenue and Forecast to 2027 (US$ Mn)
6.4.6 Other Glucose Monitoring Devices Market
6.4.6.1 Overview
6.4.6.2 Asia Pacific Other Glucose Monitoring Devices Market Revenue and Forecast to 2027 (US$ Mn)
6.5 Insulin Delivery Devices Market
6.5.1 Overview
6.5.2 Asia Pacific Insulin Delivery Devices Market Revenue and Forecast to 2027 (US$ Mn)
6.5.3 Insulin Pens Market
6.5.3.1 Overview
6.5.3.2 Asia Pacific Insulin Pens Market Revenue and Forecast to 2027 (US$ Mn)
6.5.4 Insulin Syringes Market
6.5.4.1 Overview
6.5.4.2 Asia Pacific Insulin Syringes Market Revenue and Forecast to 2027 (US$ Mn)
6.5.5 Insulin Pumps Market
6.5.5.1 Overview
6.5.5.2 Asia Pacific Insulin Pumps Market Revenue and Forecast to 2027 (US$ Mn)
6.5.6 Other Insulin Delivery Devices Market
6.5.6.1 Overview
6.5.6.2 Asia Pacific Insulin Delivery Devices Market Revenue and Forecast to 2027 (US$ Mn)

7. Asia Pacific Diabetes Care Devices Market Analysis - By End User
7.1 Overview
7.2 Asia Pacific Diabetes Care Devices Market, By End User, 2018 & 2027 (%)
7.3 Asia Pacific Diabetes Care Devices Market Revenue And Forecasts To 2027, By End User (Us$ Mn)
7.4 Homecare Market
7.4.1 Overview
7.4.2 Asia Pacific Homecare Market Revenue and Forecasts to 2027 (US$ Mn)
7.5 Hospitals & Clinics Market
7.5.1 Overview
7.5.2 Asia Pacific Hospitals & Clinics Market Revenue and Forecasts to 2027 (US$ Mn)

8. Asia Pacific Diabetes Care Devices Market Revenue And Forecasts To 2027
8.1 Overview
8.2 Asia Pacific Diabetes Care Devices Market Revenue And Forecasts To 2027 (Us$ Mn)
8.3 Asia Pacific Diabetes Care Devices Market Revenue And Forecasts To 2027, By Product (Us$ Mn)
8.3.1 Asia Pacific Glucose Monitoring Devices Market Revenue And Forecasts to 2027, By Type (US$ Mn)
8.3.2 Asia Pacific Insulin Delivery Devices Market Revenue And Forecasts to 2027, By Type (US$ Mn)
8.4 Asia Pacific Diabetes Care Devices Market Revenue And Forecasts To 2027, By End User (Us$ Mn)
8.5 Asia Pacific Diabetes Care Devices Market Revenue And Forecasts To 2027, By Country (%)
8.6 China Diabetes Care Devices Market
8.6.1 China Diabetes Care Devices Market Revenue and Forecasts to 2027 (US$ Mn)
8.6.2 China Diabetes Care Devices Market Revenue And Forecasts to 2027, By Product (US$ Mn)
8.6.2.1 China Glucose Monitoring Devices Market Revenue And Forecasts to 2027, By Type (US$ Mn)
8.6.2.2 China Insulin Delivery Devices Market Revenue And Forecasts to 2027, By Type (US$ Mn)
8.6.2.3 China Diabetes Care Devices Market Revenue And Forecasts to 2027, By End User (US$ Mn)
8.7 Japan Diabetes Care Devices Market
8.7.1 Japan Diabetes Care Devices Market Revenue and Forecasts to 2027 (US$ Mn)
8.7.2 Japan Diabetes Care Devices Market Revenue And Forecasts to 2027, By Product (US$ Mn)
8.7.2.1 Japan Glucose Monitoring Devices Market Revenue And Forecasts to 2027, By Type (US$ Mn)
8.7.2.2 Japan Insulin Delivery Devices Market Revenue And Forecasts to 2027, By Type (US$ Mn)
8.7.3 Japan Diabetes Care Devices Market Revenue And Forecasts to 2027, By End User (US$ Mn)
8.8 India Diabetes Care Devices Market
8.8.1 India Diabetes Care Devices Market Revenue and Forecasts to 2027 (US$ Mn)
8.8.2 India Diabetes Care Devices Market Revenue And Forecasts to 2027, By Product (US$ Mn)
8.8.2.1 India Glucose Monitoring Devices Market Revenue And Forecasts to 2027, By Type (US$ Mn)
8.8.2.2 India Insulin Delivery Devices Market Revenue And Forecasts to 2027, By Type (US$ Mn)
8.8.3 India Diabetes Care Devices Market Revenue And Forecasts to 2027, By End User (US$ Mn)
8.9 Australia Diabetes Care Devices Market
8.9.1 Australia Diabetes Care Devices Market Revenue and Forecasts to 2027 (US$ Mn)
8.9.2 Australia Diabetes Care Devices Market Revenue And Forecasts to 2027, By Product (US$ Mn)
8.9.2.1 Australia Glucose Monitoring Devices Market Revenue And Forecasts to 2027, By Type (US$ Mn)
8.9.2.2 Australia Insulin Delivery Devices Market Revenue And Forecasts to 2027, By Type (US$ Mn)
8.9.3 Australia Diabetes Care Devices Market Revenue And Forecasts to 2027, By End User (US$ Mn)
8.10 South Korea Diabetes Care Devices Market
8.10.1 South Korea Diabetes Care Devices Market Revenue and Forecasts to 2027 (US$ Mn)
8.10.2 South Korea Diabetes Care Devices Market Revenue And Forecasts to 2027, By Product (US$ Mn)
8.10.2.1 South Korea Glucose Monitoring Devices Market Revenue And Forecasts to 2027, By Type (US$ Mn)
8.10.2.2 South Korea Insulin Delivery Devices Market Revenue And Forecasts to 2027, By Type (US$ Mn)
8.10.3 South Korea Diabetes Care Devices Market Revenue And Forecasts to 2027, By End User (US$ Mn)

9. Diabetes Care Devices Market - Industry Landscape
9.1 Overview
9.2 Comparative Company Analysis
9.3 Growth Strategies Done By The Companies In The Market, (%)
9.4 Organic Developments
9.4.1 Overview
9.5 Inorganic Developments
9.5.1 Overview

10. Diabetes Care Devices Market-Key Company Profiles
10.1 BD
10.1.1 Key Facts
10.1.2 Business Description
10.1.3 Financial Overview
10.1.4 Product Portfolio
10.1.5 SWOT Analysis
10.1.6 Key Developments
10.2 Novo Nordisk A/S
10.2.1 Key Facts
10.2.2 Business Description
10.2.3 Financial Overview
10.2.4 Product Portfolio
10.2.5 SWOT Analysis
10.2.6 Key Developments
10.3 B. Braun Melsungen AG
10.3.1 Key Facts
10.3.2 Business Description
10.3.3 Financial Overview
10.3.4 Product Portfolio
10.3.5 SWOT Analysis
10.3.6 Key Developments
10.4 Medtronic
10.4.1 Key Facts
10.4.2 Business Description
10.4.3 Financial Information
10.4.4 Product Portfolio
10.4.5 SWOT Analysis
10.4.6 Key Developments
10.5 Tandem Diabetes Care, Inc.
10.5.1 Key Facts
10.5.2 Business Description
10.5.3 Financial Information
10.5.4 Product Portfolio
10.5.5 SWOT Analysis
10.5.6 Key Developments
10.6 Insulet Corporation
10.6.1 Key Facts
10.6.2 Business Description
10.6.3 Financial Information
10.6.4 Product Portfolio
10.6.5 SWOT Analysis
10.6.6 Key Developments
10.7 Eli Lilly And Company
10.7.1 Key Facts
10.7.2 Business Description
10.7.3 Financial Overview
10.7.4 Product Portfolio
10.7.5 SWOT Analysis
10.7.6 Key Developments
10.8 Dexcom, Inc.
10.8.1 Key Facts
10.8.2 Business Description
10.8.3 Financial Overview
10.8.4 Product Portfolio
10.8.5 SWOT Analysis
10.8.6 Key Developments
10.9 Terumo Corporation
10.9.1 Key Facts
10.9.2 Business Description
10.9.3 Financial Overview
10.9.4 Product portfolio
10.9.5 SWOT ANALYSIS
10.9.6 KEY DEVELOPMENTS
10.10 F. Hoffmann-La Roche Ltd.
10.10.1 Key Facts
10.10.2 Business Description
10.10.3 Financial Overview
10.10.4 Product Portfolio
10.10.5 SWOT Analysis
10.10.6 Key Developments

11. Appendix
11.1 About the Publisher
11.2 Glossary Of Terms
11.3 Methodology
11.3.1 Coverage
11.3.2 Secondary Research
11.3.3 Primary Research
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
  • BD
  • Novo Nordisk A/S
  • B. Braun Melsungen AG
  • Insulet Corporation
  • Medtronic
  • Tandem Diabetes Care, Inc.
  • Eli Lilly and Company
  • Dexcom, Inc.
  • Terumo Corporation
  • F. Hoffman-LA Roche Ltd.
Note: Product cover images may vary from those shown
Adroll
adroll